Additionally, down-regulation of ACSL1 in breast cancer was associated with alteration of the mTOR signaling pathway, which might be a possible candidate for treatment, and the findings were consistent with another study conducted by Liśkiewicz et al. [23]. This evidence concerns the gene ACSL1 and breast carcinoma.